Rabeprazole Based Therapy for GERD – RABINEXT

Rabeprazole is a highly effective proton pump inhibitor (PPI) used in the management of acid-related disorders such as gastroesophageal reflux disease (GERD), gastritis, peptic ulcers, and Zollinger-Ellison syndrome. By reducing stomach acid secretion, it promotes healing of the esophagus and stomach lining. Doctors frequently prescribe RABINEXT-DSR Capsules for patients needing dual action relief from acidity and reflux symptoms.

How Rabeprazole Works

Rabeprazole blocks the proton pumps in the stomach lining, directly reducing acid secretion at its source. This helps prevent acid reflux into the esophagus and allows better healing of ulcers and erosions. Its fast onset of action makes it a preferred choice among PPIs.

About RABINEXT-DSR Capsules

RABINEXT-DSR Capsules combine Rabeprazole with Domperidone in a sustained-release formulation. While Rabeprazole reduces acid secretion, Domperidone enhances gastric motility and prevents reflux-associated nausea and bloating. This dual approach offers complete management of GERD.

Key Benefits

• Rapid relief from acidity and heartburn.
• Effective healing of erosive esophagitis and gastric ulcers.
• Prevents regurgitation, bloating, and reflux-induced nausea.
• Convenient once-daily dosing for long-lasting control.

Who Should Use RABINEXT?

Patients with chronic acidity, GERD, reflux esophagitis, gastritis, or peptic ulcer disease benefit most from this therapy. RABINEXT-DSR is especially effective for those requiring long-term acid suppression with prokinetic support.

Conclusion

For comprehensive GERD and acidity management, RABINEXT-DSR Capsules combine the acid-suppressing effect of Rabeprazole with the motility benefits of Domperidone, ensuring faster relief and long-term protection.